BioLineRx annual operating margin
2023
2024
2025
BioLineRx Operating Margin Growth & History (BLRX)
BioLineRx's operating margin was −871.78% for fiscal 2025.
View full BioLineRx company overviewBioLineRx annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −871.78% | −801.26 pp |
| 2024 | 2024-12-31 | −70.52% | +964.77 pp |
| 2023 | 2023-12-31 | −1,035.29% | — |
BioLineRx quarterly operating margin
Q2.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −1,215.31% | −457.74 pp |
| Q1 2026 | 2026-03-31 | −629.77% | +307.88 pp |
| Q4 2025 | 2025-12-31 | −1,745.36% | — |
| Q3 2025 | 2025-09-30 | −516.86% | — |
| Q2 2025 | 2025-06-30 | −757.57% | −650.52 pp |
| Q1 2025 | 2025-03-31 | −937.65% | — |
| Q2 2024 | 2024-06-30 | −107.05% | — |
BioLineRx operating margin trends
Between the periods ended 2023-12-31 and 2025-12-31, BioLineRx's operating margin increased from −1,035.29% to −871.78%, a change of +163.51 percentage points. The latest reported quarter, Q2 2026, shows −1,215.31%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioLineRx source filings ↗